Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.

MLA

Jacków, Joanna, et al. “Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa Using a Self-Inactivating COL7A1 Retroviral Vector.” The Journal of Investigative Dermatology, vol. 136, no. 7, July 2016, pp. 1346–54. EBSCOhost, https://doi.org/10.1016/j.jid.2016.02.811.

APA

Jacków, J., Titeux, M., Portier, S., Charbonnier, S., Ganier, C., Gaucher, S., & Hovnanian, A. (2016). Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector. The Journal of Investigative Dermatology, 136(7), 1346–1354. https://doi.org/10.1016/j.jid.2016.02.811

Chicago

Jacków, Joanna, Matthias Titeux, Soizic Portier, Soëli Charbonnier, Clarisse Ganier, Sonia Gaucher, and Alain Hovnanian. 2016. “Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa Using a Self-Inactivating COL7A1 Retroviral Vector.” The Journal of Investigative Dermatology 136 (7): 1346–54. doi:10.1016/j.jid.2016.02.811.